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Background: The present study investigated the validity and the reliability of the oxygen uptake efficiency slope (OUES) as a determinant of
exercise tolerance in adults with cystic fibrosis (CF).
Methods: 31 CF patients and 34 healthy controls performed a maximal incremental cycle test with respiratory gas-exchange measurements. OUES
was calculated from data taken from different percentages of the entire exercise duration, including 80% (OUES80) and 100% (OUES100). Peak
oxygen uptake (VO2peak) and gas exchange threshold (GET) were also determined. The agreement between submaximal parameters and VO2peak
was assessed using Bland Altman plots. Test retest reliability was evaluated in CF patients using absolute (SEM) and relative indices (ICC).
Results: On the contrary to the GET, which was undetectable in 16% of the CF patients, the OUES was easily determined in all patients. Among
all the submaximal variables, OUES80 had the best reliability (ICC=0.94, SEM=7.3%) and agreement with VO2peak (r
2=0.83, Pb0.01; limits of
agreement: ±365 mL min−1) and did not differ from OUES100.
Conclusions: OUES80 is a reliable and more useful submaximal parameter than the GET and may find use in the interpretation of exercise studies
in CF patients who are unable to perform maximal exercise.
© 2010 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.Keywords: Cystic fibrosis; Oxygen uptake efficiency slope; Gas exchange threshold; Fitness1. Introduction
In cystic fibrosis (CF) patients, the peak oxygen uptake
(VO2peak) determined during a cardio pulmonary exercise test
has been shown to be one of the best markers of prognosis and
mortality [1,2]. However, the achievement of VO2peak may be
influenced by motivation, pain, shortness of breath and fatigue
and some patients may have difficulties achieving a maximal
exercise test. These issues may be of particular concern when
studying patients with chronic airflow limitation [3]. Conse-
quently, several submaximal variables have been used to⁎ Corresponding author. HandiBio, EA 4322, Université du Sud Toulon-Var,
Avenue de l'Université, BP 20132, 83957 La Garde Cedex, France. Tel.: +33 4
94 14 27 57; fax: +33 4 94 14 22 78.
E-mail address: vallier@univ-tln.fr (J.M. Vallier).
1569-1993/$ - see front matter © 2010 European Cystic Fibrosis Society. Publishe
doi:10.1016/j.jcf.2010.03.003evaluate aerobic fitness without performing a maximal exercise.
The anaerobic threshold, determined by the measurement of
blood lactate concentration (lactate threshold), is considered a
useful index of functional capacity for patients suffering from
chronic airflow limitation [4]. In CF patients, the anaerobic
threshold can be reliably estimated by the hyperventilatory
response to the exercise-induced metabolic acidosis (the
ventilatory [VT] or gas exchange threshold [GET]) [5]. The
non invasive nature of the GET makes it more acceptable to
patients than the lactate threshold which requires blood
sampling. The VT and GET are widely used in CF patients
[5,6]. Unfortunately, it is well known that these thresholds
cannot be always determined in patients with chronic airflow
limitation [5,7] and are dependent on numerous factors,
including the characteristics of the protocol, the method of
detection, and the intra or inter observer variability [8,9].d by Elsevier B.V. All rights reserved.
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clinically useful submaximal measure of cardiorespiratory
fitness, Baba et al. introduced the oxygen uptake efficiency
slope (OUES), derived from the logarithmic relation between
oxygen uptake (VO2) and minute ventilation (VE) during
incremental exercise [10]. The OUES has a limited dependence
towards the duration (or intensity) of the exercise and can be
used in patients unable to perform a really maximal incremental
test [11]. Initially, this index has been clinically applied in
healthy subjects and in patients with heart disease [10]. At
present, numerous data exists for different pathologies and
conditions such as obesity [12], renal deficiency [13], ischemia
[14] and hypoxia [15]. The OUES, even if calculated from only
part of the test, is always determinable [10], reliable [16] and
highly correlated with VO2peak [10]. This index reflects oxygen
extraction efficiency in the lungs and its utilisation in the
periphery. It is determined by plasma pH, arterial carbon
dioxide and dead space/tidal volume ratio (Vd/Vt), all of which
may be influenced by CF [17,18]. No studies to date have been
conducted in patients with chronic airflow limitation such as
CF. As regards of the importance of accurately evaluating
exercise tolerance in CF patients and to the numerous
limitations of traditional indexes, the OUES might be a very
attractive alternative for assessing aerobic fitness in this
population.
Therefore, the purpose of this study was to determine the
clinical usefulness of the OUES in CF patients by investigating
(1) its dependence on the duration of the test (2) its agreement
with VO2peak and (3) its test–retest reliability.2. Method
2.1. Patients
In total, 31 adults with CF (25 men and 6 women) were
recruited from the Giens adult CF center (CRCM, Giens,
France). All subjects had CF diagnosis based on clinical
features, abnormal sweat test and genotyping, and had clinical,
radiologic and physiologic evidence of CF-related lung disease.
All patients had mild to moderate lung disease. All were
clinically stable for a period of one month prior to taking part in
the study. All had a pancreatic disease and received a specific
supplementation in pancreatic enzymes, vitamins A, D, E and
NaCl. None of the patients were receiving long-term oxygen
therapy. 34 adults controls (29 men and 5 women) of a similar
age who were free from respiratory, cardiac or musculoskeletal
diseases were also recruited from the hospital staff and visitors.
The aims of the study were explained to the subjects, and they
all gave informed written consent prior to participation. This
study was approved by the Local Ethics Committee and was
conducted in accordance with the declaration of Helsinki.
Lung function measurements were performed using a whole
body plethysmograph (Oxycon Champion, Jaeger, Breda, New
Zealand). Forced vital capacity (FVC) and forced expiratory
volume in one second (FEV1) were recorded as a percentage of
predicted values for gender and height [19].2.2. Exercise testing
All the 65 subjects were initially familiarized with the exercise
equipment and were then instructed to perform progressive
exercise to a symptom-limited maximum using a mechanically
braked cycle ergometer (Monark, 824E, Stockolm, Sweden).
Following baseline measurements (1 min), participants com-
menced a 3 min warm-up at 30 W, after which the workload was
increased by 12 W/min for CF patients and 30 W/min for CO
group. Incremental workloads were chosen in order to attain peak
power output within 10–15 min. Subjects were asked to maintain
a cadence of 60 revolutions/min throughout the test. All were
instructed to pedal until they could no longer exercise, in an
identical manner by the same trained operator. No other type of
encouragement was offered and no communication was made
with the subjects during the testing to ensure consistency of the
protocol.
Four weeks later, seventeen CF patients performed an
additional symptom-limited cycle test in the same experimental
conditions to evaluate test–retest reliability.
2.3. Respiratory gas measurements
During exercise testing, expired gas were continuously
measured using a breath by breath telemetric system (Cosmed
K4b2, Rome, Italy) [20]. Carbon dioxide production (VCO2),
VE and VO2, were measured breath by breath. Heart rate (HR)
(Polar RS 400, electro oy, Kempele, Finland) was continuously
monitored. Oxygen saturation (SpO2) was continuously mon-
itored using pulse oxymetry (Nonin 9500 Onyx, Plymouth,
USA). The peak exercise variables were calculated as an
average of 30 s prior to the termination of the exercise. Peak
exercise rating of perceived exertion (RPE) was measured
immediately at the end of the test using a Borg 6-20 RPE scale
[21]. A test was considered to be at or near the maximal level if
at least two out of the four following criteria were met: peak
VO2N85% predicted; peak HRN85% predicted; respiratory
exchange ratioN1.09; RPE≥18 [12].
2.4. Determination of submaximal indices
The GET was determined visually, in a blinder manner using
the modified V-slope method [22]. This method assumes that
GET corresponds to the breakpoint during the exercise test
where VCO2 begins to rise disproportionately faster than VO2,
due to the bicarbonate buffering of the acidosis. Any inflection
point occurring before 2 min was rejected on the basis that it
may represent a “pseudothreshold” due to transient changes in
carbon dioxide stores [23]. The GET was calculated as an
average of 10 s before and after the selected threshold.
The relationship between VO2 and VE was expressed by the
OUES. In almost all patients, the index was best described by a
single logarithmic curve-fitting model [10]. As such, using data
starting from 2 min after exercise began [15], the following
equation was applied: VO2=a× log VE+b, where the constant
a represents the rate of increase in VO2 in response to an
increase in VE. This constant is denominated OUES and was
Table 1
Baseline and exercise data of the study population.
Variables CF group (N=31) controls (N=34) P level
Men/women gender, number 25/6 29/5
Age, yr 26.9 (6.0) 26.8 (9.0) P=0.56
Height, cm 170 (7.8) 177 (7.1) Pb0.01
Weight, kg 59.6 (6.2) 73.4 (9.4) Pb0.01
BMI, kg/m2 20.7 (2.2) 23.3 (2.1) Pb0.01
FEV1, L [% predicted] 1.9 (0.6) [52] 4.3 (0.7) [105] Pb0.01
FVC, L [% predicted] 3.41 (0.7) [76] 5.42 (1.2) [110] Pb0.01
VO2peak, mL min
−1
[% predicted]
1798 (461) [67] 2939 (547) [95] Pb0.01
VO2peak, mL min
−1 kg−1 30.7 (7.0) 40.2 (6.9) Pb0.01
GET, mL min−1 1153 (352) 1749 (418) Pb0.01
OUES50, mL min
−1 logL−1 2013 (651) 3049 (735) Pb0.01
OUES60, mL min
−1 logL−1 2190 (687) 3139 (653) Pb0.01
OUES70, mL min
−1 logL−1 2313 (653) 3223 (612) Pb0.01
OUES80, mL min
−1 logL−1 2332 (573) 3237 (635) Pb0.01
OUES100, mL min
−1 logL−1 2345 (549) 3259 (681) Pb0.01
Peak workload, watts 134 (12) 275 (54) Pb0.01
Peak heart rate, bpm 174 (12) 186 (13) Pb0.05
Oxygen desaturation, % 3.5 (1.7) 1.8 (0.6) Pb0.01
Data are given as mean (SD); CF = cystic fibrosis; CO = control; BMI = body
mass index (weight/height2).
Fig. 1. OUES values calculated from data taken from the first 50% (OUES50),
60% (OUES60), 70% (OUES70), 80% (OUES80) and 100% (OUES100) of the
entire exercise duration and expressed relative to weight in CF patients and
controls. Values are given as the mean (SD). *Pb0.05, **Pb0.01: CF patients
vs controls; †Pb0.05, ††Pb0.01: effect of exercise duration.
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(OUES60), 70% (OUES70), 80% (OUES80) and 100%
(OUES100) of the entire maximal exercise duration. OUES
values were also expressed relative to weight.
2.5. Statistical analysis
All analyses were performed with Statistica 7.0 (Statsoft,
Tulsa, OK, USA). The results were expressed as mean (SD). The
level of significance was set at Pb0.05. Unpaired t-tests were
used to detect significant differences in VO2peak, GET and
OUES values between the CF and CO group. The relations
between VO2peak and submaximal variables were assessed by
linear regression analysis. The regression equations were then
used to predict VO2peak from each subject's OUES and GET
values. The Bland–Altman technique [24] was used to evaluate
the agreement between measured VO2peak and VO2peak
predicted from OUES50 (P50VO2peak), OUES60 (P60VO2peak),
OUES70 (P70VO2peak), OUES80 (P80VO2peak), OUES100 (P100-
VO2peak) and GET (PGETVO2peak). For each subject, the average
of predicted and measured VO2peak was plotted against the
difference between the two values. The limits of agreement
(LoA) were calculated by adding and subtracting 1.96×SD of
the differences from the mean value.
To identify whether OUES was exercise duration dependent,
repeated-measures ANOVA with post hoc analysis was used to
test for differences between OUES50, OUES60, OUES70,
OUES80 and OUES100.
The reliability of VO2peak, GET and OUES values was
assessed in the CF group using different absolute and relative
indices. The intra-class correlation coefficient (ICC) was
determined using the model 2,1 [25]. The following general
guidelines were used [26]: 0–.25 poor, .40–.59 fair, .60–.79
good, .80–1.0 excellent. The standard error of measurement
(SEM)was calculated to obtain an absolute measure of reliability.
The SEMwas also used to determine the Minimum Difference to
be considered “real” (MD), calculated as follows [27]:
MD = SEM × 1:96 ×
ﬃﬃﬃ
2
p
3. Results
3.1. Profile of subjects and group comparisons
Baseline characteristics and exercise data of participants in
this study are presented in Table 1. VO2peak, GET and OUES,
expressed in absolute values or relative to weight, were all
significantly lower in the CF group in comparison to controls
(Table 1 and Fig. 1).
According to the criteria previously stated, 100% of the
controls performed a maximal exercise and reached VO2peak. In
addition, theGETwas identified in all of these subjects. 6 of 31CF
patients (19%) did not reach amaximal exercise level andwere not
included in the analysis of OUES. 4 of the remaining 25 CF
patients (16%) demonstrated a pseudothreshold and noGET could
be identified; they were not included in the GET analysis. TheOUES, at all exercise duration, was easily determined in both
groups.
3.2. Relationship between OUES and fitness and exercise
duration
Whatever the group or the exercise duration, the OUES
values were significantly related to VO2peak (r
2 ranging from
0.51 to 0.83, Pb0.01). The GET was significantly related to
VO2peak in CF (r
2 =0.72, Pb0.01) (Fig. 2a) and in controls
(r2 =0.64, Pb0.01). Among all submaximal parameters,
OUES80 was the best correlated with VO2peak in CF patients
(r2 =0.83, Pb0.01) (Fig. 2c). The linear regression revealed that
VO2peak was predicted by OUES80, using the following
equation: VO2peak=0.737×OUES80+80.76.
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ranging from ±365 to ±512 mL min−1 in the CF group and
±555 to ±752 mL min−1 in controls (Table 2). The LoA for
GET were ±510 mL min−1 in CF patients (Fig. 2b and Table 2)
and ±651 mL min−1 in controls (Table 2). In both groups, the
comparisons between the measured VO2peak and P80VO2peak
demonstrated the closest 95% confidence intervals (Fig. 2d for
CF patients and Table 2).
In both groups, OUES70 and OUES80 did not differ from
OUES100 (Fig. 1). Among all OUES values, OUES80was the best
correlated with OUES100 in CF patients (r
2=0.86, Pb0.01).
3.3. Reliability of VO2peak and submaximal variables
17 CF patients from the 31 initially enrolled participated in the
reliability analysis. The reliability values for all parameters are
shown in Table 3. Mean FEV1 and FVC were not different
between the two occasions. All the variables showed excellent
relative reliability (ICC ranged from 0.86 to 0.94). OUES80
demonstrated the best absolute reliability compared to VO2peak
and GET (SEM=7.3%, 8.5% and 9.7%, respectively).
4. Discussion
This study was designed to validate OUES as a new
submaximal determinant of exercise tolerance in CF patients. It
was demonstrated that OUES can easily be determined in all CF
patients and has a limited dependence towards the duration of the
exercise. Furthermore, among all submaximal variables, we found
that OUES80 has the best reliability and agreement with VO2peak.
Possibly because exercise requires the integrated functioning
of multiple organs in multisystem diseases such as CF, exercise
capacity has been shown to be one of the strongest markers of
prognosis and mortality [2]. The actual recommendations for
interpretation of cardiopulmonary exercise test, however,
necessitate that the subjects achieve a maximal effort. Many
CF patients cannot or will not perform to a maximal level for a
variety of subjective reasons, questioning the “gold standard
status” of VO2peak in these patients. The fact that almost 20% of
our patients did not achieve VO2peak highlights the need for a
suitable submaximal measurement of fitness in such indivi-
duals. Baba et al. [10] introduced the OUES as a novel index
derived from the logarithmic relation between VO2 and VE
during incremental exercise. We extrapolated the observations
of Baba et al. to a group of CF patients with mild to moderate
lung disease.
As previously described [5], VO2peak and GET, expressed in
absolute values or relative to weight, were significantly lower in
CF patients compared to controls. The fact that the OUES wasFig. 2. Assessment of the agreement between GET and VO2peak (top left, a, and top
right, b) and betweenOUES80 andVO2peak (bottom left, c, and bottom right, d) in CF
patients. a and c: VO2peak plotted against GET and OUES80. b: Average of the
VO2peak predicted by GET (PGETVO2peak) and the measured VO2peak plotted against
the difference between the two values. d: Average of the VO2peak predicted by
OUES80 (P80VO2peak) and the measured VO2peak plotted against the difference
between the two values. The solid line indicates the mean of the differences. The
dashed lines indicate the limits of agreement (i.e. ±1.96 SD of the differences).
Table 2
Agreement between measured VO2peak and VO2peak predicted from GET and OUES values.
Variables CF CO
LOA mL min−1 LOA % average VO2peak LOA mL min
−1 LOA % average VO2peak
VO2peak−P50VO2peak 512 28 674 22.9
VO2peak−P60VO2peak 487 26.8 752 25.6
VO2peak−P70VO2peak 465 25.6 636 21.6
VO2peak−P80VO2peak 365 20 555 18.9
VO2peak−P100VO2peak 390 21 559 19
VO2peak−PGETVO2peak 510 27 651 22.2
CF = cystic fibrosis; CO = control; LOA = limits of agreement.
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test confirms its capability to detect differences in fitness. Similar
to results of previous studies, OUES at all intensities was
significantly related to VO2peak in both groups [10–12,15,28].
Moreover, we found that OUES70 and OUES80 were not different
fromOUES100 in both groups, confirming the limited dependence
of the OUES towards the duration or intensity of the test. Finally,
inCF patients, theOUES calculated on only 80%of thewhole test
duration was the best correlated with VO2peak and was not
significantly different and highly correlated with OUES100. Thus,
taken together, these observations highlight the role of OUES80 in
the assessment of fitness in patients unable to achieve a maximal
effort.
As outlined by Pichon et al. [29], the fact that two parameters
are not different and correlated does not imply that they are
interchangeable. The Bland–Altman method has been devel-
oped for that purpose. A controversial point, however, is the
choice of criteria used to define acceptable LoA for predicted
VO2peak relative to measured VO2peak. There does not appear to
be an accepted “gold standard” criterion among exercise
physiologists. We found similar LoA for OUES values in
both groups (when expressed in % meanVO2peak), and LoA for
OUES80 of ±365 mLmin
−1 in the CF group. These LoA are not
satisfactory according to criteria defined in one recent study
[12] but are completely acceptable in numerous others
[5,29,30].
When considering any new index, an additional benefit over
the current standard needs to be demonstrated. Several
submaximal variables, mainly including VT and GET, have
been used to evaluate cardiopulmonary functional reserve
without requiring subjects to perform maximal exercise.
Because of the failure to detect the VT in the majority of theTable 3
Absolute and relative reliability of cardio pulmonary exercise test parameters in the
Variables Mean (SD)
Test Retest
VO2peak, mL min
−1 1669 (569) 1599 (470
GET, mL min−1 972 (321) 1067 (404
OUES50, mL min
−1 logL−1 1923 (623) 1866 (633
OUES60, mL min
−1 logL−1 2065 (708) 1972 (615
OUES70, mL min
−1 logL−1 2176 (689) 2119 (630
OUES80, mL min
−1 logL−1 2194 (641) 2156 (620
OUES100, mL min
−1 logL−1 2241 (586) 2183 (578
ICC = intra-class coefficient; SEM = standard error of measurement; MD = minimuCF patients, due to the absence of a significant hyperventilatory
response [5], this threshold was not considered in our study and
cannot be used to reliably assess fitness in CF. However, the
GET is valid, provides an unbiased estimation of the lactate
threshold and is one of the usual primary outcome variables in
exercise studies in CF. Consequently, a new outcome measure
like OUES can be considered clinically useful if its use can offer
an advantage over the GET. The rate of successful GET
determination usually varies from 30 to 90% [5–7,22]. In our
study, the frequency with which the GET could be detected in
the CF group (i.e. 84%) was consistent with this range. The
OUES, at all exercise durations, was easily determined in both
groups. Moreover, contrary to the GET [31], the OUES is
calculated mathematically in all subjects and thus its measure-
ment is free from intra and inter-rater variability. Because the
OUES is determined from a ratio, it might, in contrast to
VO2peak and GET measurements, be insensitive to the metabolic
cart and protocol used. Within this framework, Baba et al. found
an excellent interprotocol agreement for the OUES in healthy
children, whereas VO2peak and GET were both associated with
poorer agreement [28]. Although addressing this issue will
require further investigations, we can reasonably expect to
obtain the same results in CF patients. Furthermore, since the
reference method in CF for the GET detection is based on the
visual inspection of ventilatory data plots, this is logical that its
determination is more time-consuming than the OUES
calculation. Indeed, even without routine calculation, only 30-
s are sufficient to determine OUES through calculating log VE
and plotting log VE vs. VO2.
Finally, the OUES80 demonstrated a better correlation and
agreement with VO2peak than the GET. Thus, as regards to the
several limitations of the GET in this population, our findingscystic fibrosis (CF) group (n=17).
ICC SEM (%) MD (%)
) 0.93 138 (8.5) 383 (23.6)
) 0.92 99 (9.7) 275 (27.0)
) 0.86 234 (12.4) 650 (34.3)
) 0.90 213 (10.5) 589 (29.2)
) 0.92 190 (8.9) 528 (24.6)
) 0.94 160 (7.3) 442 (20.4)
) 0.90 184 (8.3) 510 (23.1)
m difference.
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determinant of fitness in CF patients.
In order to assess the clinical significance of repeated cardio
pulmonary exercise testing, we examined the test–retest reliability
of the OUES, GET and VO2peak in the CF group. Mean FEV1 and
FVC were not different between test and retest, indicating that the
CF patients were in clinically stable condition over the period of
testing [5]. In the present study, the GET and VO2peak were both
associated with low variability, that is consistent with previous
findings in CF patients [5]. However, few studies to date have
evaluated the test retest reliability of the OUES. We found that
OUES demonstrated a satisfactory reliability in CF patients, which
increased when calculated from elevated levels of exercise
intensity. These results are in agreement with those recently
achieved in healthy subjects [16]. The slightly lower test–retest
reliability detected for VO2peak and GET in comparison to OUES80
may be explained, respectively, by test–retest differences in
motivation and by intra-observer variability. The excellent absolute
and relative reliability of the OUES80 confirms its clinical
usefulness and superiority towards the GET.
This study was limited by the small number of subjects
recruited, the majority of whom demonstrated mild to moderate
CF. The equation used in this study to predict VO2peak (i.e.
VO2peak=0.737×OUES80+80.76) seems valid for these patients
but might be inappropriate for those with severe lung disease. The
establishment of reference equations and corresponding LoA to
predict VO2peak fromOUES values will require a larger sample of
patients across the disease spectrum. Until such equations are
available, the information provided by the OUES should be
considered complementary to VO2peak, not a replacement for it.
Finally, it would be also interesting to evaluate the prognostic
value of OUES in CF patients.
In summary, the OUES calculated from only 80% of the test
duration, was always detectable, highly correlated with VO2peak
and was not different from OUES100 in CF patients. Furthermore,
among all submaximal parameters,OUES80 demonstrated the best
reliability and agreement with VO2peak. Therefore, OUES80 might
be considered as a useful submaximal index of cardiorespiratory
fitness in CF patients and may find use in the interpretation of
exercise studies, particularly in subjects unable to achieve a
maximal effort.
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